SUBSCRIBE
SUBSCRIBE
News   Business

Antares Pharma, Inc. Reports Fourth Quarter and Full Year 2011 Financial and Operating Results

March 12, 2012 | 
1 min read
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today reported financial and operating results for the fourth quarter and full year ended December 31, 2011 and outlined key objectives and milestones for 2012.
Earnings
MORE ON THIS TOPIC
Two men walking on separate winding paths that merge into a single large upward arrow representing business partnership and shared goals, 3d render
Mergers & acquisitions
Telix buys ITM for $1.65B in ‘supercritical’ radiopharma M&A
September 21, 2026
 · 
3 min read
 · 
Tristan Manalac
Contemporary art collage. Businessman standing under heavy pressure. Working conditions. Concept of struggle, failure, success, competition, motivation, concentration, crisis, fear Copy space for ad
Obesity
Novo buys three early-stage obesity assets from Kallyope as investor pressure mounts
September 21, 2026
 · 
1 min read
 · 
Tristan Manalac
Symbolic image: Tablets, US Dollar and China - Dependence on the Chinese pharmaceutical industry
China
China plans to transform biotech sector into $522B powerhouse by 2030
September 18, 2026
 · 
2 min read
 · 
Annalee Armstrong
The intertwining wires flash in different colors, 3D rendering illustration.
IPO
Electra lights up with $350M IPO for pivotal immune-disease drug development
September 18, 2026
 · 
1 min read
 · 
Gabrielle Masson